Chronic kidney disease (CKD) of any etiology is associated with cardiovascular disease and is more predictable in patients with diabetic nephropathy.1 Such individuals have an increased incidence of coronary artery disease and hypertension but also can have diabetic cardiomyopathy due to microvascular complications of diabetes.2 Optimal blood pressure, blood sugar, and blood lipid control as well as cessation of smoking are of utmost importance in preventing progression of cardiovascular, renal, and end-organ damage. Similarly, early recognition and treatment of microalbuminuria (a manifestation of systemic endothelial dysfunction) is extremely important in improving cardiovascular and renal outcomes.3

Diabetic nephropathy represents the most common etiology for stage 5 chronic kidney disease in the United States, resulting in the need for dialysis and transplantation. It is estimated that about one-third of U.S. patients who need renal replacement therapy are diabetics.
" />

Chronic kidney disease (CKD) of any etiology is associated with cardiovascular disease and is more predictable in patients with diabetic nephropathy.1 Such individuals have an increased incidence of coronary artery disease and hypertension but also can have diabetic cardiomyopathy due to microvascular complications of diabetes.2 Optimal blood pressure, blood sugar, and blood lipid control as well as cessation of smoking are of utmost importance in preventing progression of cardiovascular, renal, and end-organ damage. Similarly, early recognition and treatment of microalbuminuria (a manifestation of systemic endothelial dysfunction) is extremely important in improving cardiovascular and renal outcomes.3

Diabetic nephropathy represents the most common etiology for stage 5 chronic kidney disease in the United States, resulting in the need for dialysis and transplantation. It is estimated that about one-third of U.S. patients who need renal replacement therapy are diabetics.
"> Article Full Text – Methodist Journal
Methodist Journal

FEATURED GUEST EDITOR

ISSUE INTRO

The Burgeoning Field of Cardio-Oncology

See More
RECOGNITIONS

Barry H. Trachtenberg Leads Issue on Cardio-Oncology

See More

REVIEW ARTICLES See More

Heart Failure in Relation to Anthracyclines and Other Chemotherapies

Heart Failure in Relation to Tumor-Targeted Therapies and Immunotherapies

The Role of Cardiovascular Imaging and Serum Biomarkers in Identifying Cardiotoxicity Related to Cancer Therapeutics

Prevention and Treatment of Chemotherapy-Induced Cardiotoxicity

Cardiovascular Toxicities of Radiation Therapy

Electrophysiologic Complications in Cancer Patients

Vascular Toxicity in Patients with Cancer: Is There a Recipe to Clarify Treatment?

Future Directions in Cardio-Oncology

CASE REPORTS See More

A Rare Case of Pancreatitis-Induced Thrombosis of the Aorta and Superior Mesenteric Artery

Anomalous Origin of the Right Coronary Artery from the Left Main Coronary Artery in the Setting of Critical Bicuspid Aortic Valve Stenosis

Simultaneous Transfemoral Mitral and Tricuspid Valve in Ring Implantation: First Case Report with Edwards Sapien 3 Valve

Uneventful Follow-Up 2 Years after Endovascular Treatment of a High Flow Iatrogenic Aortocaval Fistula Causing Pulmonary Hypertension and Right Heart Failure

MUSEUM OF HMH MULTIMODALITY IMAGING CENTER See More

Do Not Pass Flow: Microvascular Obstruction on Cardiac Magnetic Resonance After Reinfarction Following Primary Percutaneous Coronary Intervention

CLINICAL PERSPECTIVES See More

EXCERPTA

Cardio-Oncology, Then and Now: An Interview with Barry Trachtenberg

POINTS TO REMEMBER

Onconephrology: An Evolving Field

POINTS TO REMEMBER

Herbal Nephropathy

EXCERPTA

Rolling the Dice on Red Yeast Rice

EDITORIALS

Letter to the Editor in Response to “Cardiac Autonomic Neuropathy in Diabetes Mellitus”

Vol 6, Issue 2 (2010)

Article Full Text

REVIEW ARTICLES

The Heart And Diabetic Nephropathy

Jump to:
Article Citation:

Juan Jorge Olivero Jr., Peter T. Nguyen, Juan Jose Olivero, and Anna Kagan (2010) The Heart And Diabetic Nephropathy. Methodist DeBakey Cardiovascular Journal: April 2010, Vol. 6, No. 2, pp. 9-14.

doi: https://doi.org/10.14797/mdcj-6-2-9

Abstract

Chronic kidney disease (CKD) of any etiology is associated with cardiovascular disease and is more predictable in patients with diabetic nephropathy.1 Such individuals have an increased incidence of coronary artery disease and hypertension but also can have diabetic cardiomyopathy due to microvascular complications of diabetes.2 Optimal blood pressure, blood sugar, and blood lipid control as well as cessation of smoking are of utmost importance in preventing progression of cardiovascular, renal, and end-organ damage. Similarly, early recognition and treatment of microalbuminuria (a manifestation of systemic endothelial dysfunction) is extremely important in improving cardiovascular and renal outcomes.3

Diabetic nephropathy represents the most common etiology for stage 5 chronic kidney disease in the United States, resulting in the need for dialysis and transplantation. It is estimated that about one-third of U.S. patients who need renal replacement therapy are diabetics.

Keywords
diabetic neuropathy , diabetes , chronic kidney disease , cardiovascular disease , CVD

Add Comments

Please login to dialogue with author.

Comments